Cue Biopharma
100 hedge funds and large institutions have $89.2M invested in Cue Biopharma in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 10 closing their positions.
Holders
100
Holders Change
+10
Holders Change %
+11.11%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
28
Reduced
28
Closed
10
Calls
$1.11M
Puts
$752K
Net Calls
+$360K
Net Calls Change
-$17K
Top Buyers
| 1 |
PM
1
Prosight Management
Dallas,
Texas
|
$7.37M |
| 2 |
SMH
2
Sanders Morris Harris
Houston,
Texas
|
$4.26M |
| 3 |
3
Renaissance Technologies
New York
|
$2.53M |
| 4 |
BL
4
Bleichroeder LP
New York
|
$2.69M |
| 5 |
CC
5
Carlson Capital
Dallas,
Texas
|
$1.98M |
